GBA1 and Parkinson disease: While the genetic link between GBA1 mutations and synucleinopathies such as PD and LBD is the strongest argument linking GCase deficit with the appearance of synucleinopathies, the ultimate basis for this association has remained elusive, with very little experimental evidence to date.